Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Latest filing published 11 Sept 2026 for Aardvark Therapeutics, Inc., €63k. Read the official filing
Filing timeline
BuySaleNelson Sun
Insider track record
Disclosed buys
2
Disclosed sells
2
T+90 hit rate
50%
T+90 mean return
+7.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Nelson Sun: trading record in brief
This profile gathers the share dealings of Nelson Sun in Aardvark Therapeutics, Inc. Over a trading history stretching from 14 February 2025 to 11 September 2026, the count stands at 5 filings.
The open-market side counts 2 purchases for €78k alongside 2 sales for €340k. Taken together, the sales exceed the purchases by €262k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show no purchases and 2 sales.
On 11 September 2026 came the latest disclosure, an open-market sale for €63k in Aardvark Therapeutics, Inc. The clock since the last published purchase (12 December 2025) now reads 310 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Nelson Sun
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
14,754 shares@ US$5.0006Common Stock, par value $0.00001 per shareSEC:0001193125-26-389564:0
62,000 shares@ US$5.1803Common Stock, par value $0.00001 per shareSEC:0001193125-26-389564:1
3,000 shares@ US$14.4047.1% of flowCommon StockSEC:0001193125-25-318070:0
Canonical exit: 11 Mar 2026 (T+90)
6,000 shares@ US$8.0733100.0% of flowCommon StockSEC:0001193125-25-200226:0
Canonical exit: 8 Dec 2025 (T+90)
7,001 sharesCommon StockSEC:0000950170-25-023243:0
5 of 5 declarations
